LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Estradiol treatment in a large cohort of younger women with congenital hypogonadism: how much is enough?

Photo by schluditsch from unsplash

17beta-Estradiol (E2 ) is a critical contributor to women's bone-, cardiovascular-, sexual- and general health during normal reproductive life, and young women with hypogonadism (YWH) therefore require hormone replacement therapy… Click to show full abstract

17beta-Estradiol (E2 ) is a critical contributor to women's bone-, cardiovascular-, sexual- and general health during normal reproductive life, and young women with hypogonadism (YWH) therefore require hormone replacement therapy (HRT) to mitigate symptoms, protect against adverse long-term health outcomes and maintain quality of life. This article is protected by copyright. All rights reserved.

Keywords: hypogonadism; estradiol treatment; large cohort; younger women; treatment large; cohort younger

Journal Title: Clinical Endocrinology
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.